If you’re a man over 50 looking at TRT, there’s a decent chance this question shows up before the first prescription ever does: what happens to cholesterol?

Fair question. Nobody wants to trade better energy, better libido, and better body composition for a worse lipid panel and a lecture from the cardiologist three months later. The internet usually handles this with two equally unhelpful positions: TRT is dangerous for your heart, or TRT fixes everything short of the tax code. Neither is serious.

The data says something more useful. In men with confirmed low testosterone, TRT’s effects on cholesterol are usually neutral to favorable. Total cholesterol often comes down. LDL often improves. Triglycerides often improve more than people expect. HDL is the messy part, but not in the cartoon-villain way it’s often presented. For men over 50, the real question isn’t “Does TRT ruin my lipids?” It’s “What usually changes, how much, and does the overall cardiovascular picture still make sense?”

TRT Effects on Cholesterol in Men Over 50: The Big Picture

Start with the point that matters most: lipid changes do happen on TRT, but the best modern safety data doesn’t show a meaningful increase in major cardiovascular events when testosterone is prescribed appropriately.

The headline study here is TRAVERSE, published in the New England Journal of Medicine in 2023. It followed 5,246 men ages 45 to 80 with low testosterone and elevated cardiovascular risk. Major adverse cardiac events occurred in 7.0% of the testosterone group and 7.3% of the placebo group. That established non-inferiority, which is clinical-trial language for: testosterone did not perform worse on the main heart-risk endpoint that everyone was worried about.

Cleveland Clinic’s summary of TRAVERSE made the practical point plain. When testosterone is used as indicated in men who actually meet diagnostic criteria, the old blanket fear around heart attacks and strokes looks a lot shakier than it did a decade ago.

Regulators noticed. In February 2025, the U.S. Food and Drug Administration removed the boxed warning about increased cardiovascular risk from testosterone product labels, citing the TRAVERSE results. That doesn’t mean TRT is a free-for-all. The FDA also added blood pressure monitoring language, which is a reminder that “safer than feared” and “ignore monitoring” aren’t the same thing.

So the frame for the rest of this article is simple: if you’re evaluating TRT and your lipid panel matters to you, you should expect changes worth tracking, but not panic over headlines that are now behind the evidence.

Total Cholesterol and LDL: The Reductions the Data Actually Shows

This is the most consistent part of the story. In older men with low testosterone, total cholesterol and LDL usually move in the right direction on TRT.

One of the older but still useful papers is the 1996 Atherosclerosis study by Zgliczynski and colleagues. After 12 months of TRT in aging men with low testosterone, total cholesterol fell from 225 to 198 mg/dL. LDL dropped from 139 to 118 mg/dL. Those aren’t rounding-error changes. They’re big enough that a man looking at his own labs would notice them immediately.

The Testosterone Trials, reported by Endocrine Today in 2017, found the same pattern in a larger modern sample. In 788 men age 65 and older, testosterone therapy produced a 6.1 mg/dL greater reduction in total cholesterol versus placebo. That’s less dramatic than the older Atherosclerosis numbers, but it points in the same direction.

The 2016 Asan Medical Center study, published in Translational Andrology and Urology, adds another useful benchmark for real-world readers. In 230 men with a mean age of 60.1, total cholesterol decreased from 183.7 to 175.5 mg/dL at six months, with a reported P value of 0.001.

That pattern matters because a lot of men come into TRT conversations assuming testosterone and cholesterol move in opposite directions by default. The evidence doesn’t support that assumption. In men with true testosterone deficiency, correcting the deficiency often improves the lipid profile rather than worsening it.

It also helps explain why men who are already digging into Normal Testosterone Level for Men Over 50 should care about more than total testosterone alone. The downstream picture includes lipids, insulin sensitivity, body composition, and how the whole system behaves after treatment starts.

HDL Cholesterol: The Complicated Story

HDL is where people get jumpy, and not without reason. If you’ve heard that testosterone can lower “good cholesterol,” you have heard a partial truth that tends to get stripped of context until it becomes nonsense.

The nuance starts with actual trial data. In the 1996 Atherosclerosis study, HDL did not decrease significantly over 12 months of TRT. The 2016 Asan study found essentially the same thing: HDL was 50.2 mg/dL at baseline and 49.5 mg/dL at 12 months, which is about as close to unchanged as real medicine gets.

Longer-term studies sometimes show HDL increases. Reviews of HDL subfractions also suggest that HDL2, the more anti-atherogenic subfraction, may remain stable or even increase even when total HDL shows a modest dip. That distinction matters because a one-number view of HDL can oversimplify what is happening underneath.

There is also an unglamorous but important dosing point here. More significant HDL suppression is more often associated with supraphysiologic dosing or with oral testosterone formulations, not with well-monitored physiologic replacement. This is one of those cases where “TRT” gets treated as one monolithic thing when it clearly isn’t. A tightly managed replacement protocol isn’t the same as blasting past normal levels because somebody at a strip-mall clinic thinks subtlety is for cowards.

For men over 50, the practical takeaway is that a small HDL shift should be interpreted in context, not as an automatic sign that the therapy is failing or dangerous. If total cholesterol, LDL, triglycerides, blood pressure, symptoms, and body composition are all moving in a better direction, a flat or slightly lower HDL value doesn’t tell the whole story.

Triglycerides: The Underappreciated Improvement

Triglycerides rarely get the same airtime as LDL, but they deserve more attention in this conversation.

In the Asan study, triglycerides fell from 147.2 to 131.2 mg/dL after six months of TRT, with a P value of 0.009. That’s a meaningful shift, especially for men who already have the familiar cluster of midlife issues that likes to travel together: central weight gain, lower energy, worse insulin sensitivity, and a lipid panel that keeps drifting in the wrong direction.

This is why the “TRT hurts cholesterol” line is usually too blunt to be useful. Even if somebody fixates on a hypothetical HDL wobble, he can miss the fact that triglycerides often improve, and that improvement matters for the broader metabolic picture.

Multiple studies and meta-analyses have reported the same general pattern, and the Translational Andrology and Urology findings fit that larger trend. That doesn’t mean every man will see the same drop. It does mean triglyceride improvement is common enough that it should be part of any honest conversation about TRT and cardiovascular risk.

If you’re also wondering whether you even fit the profile for a proper workup, Low Testosterone Symptoms Men Over 45 Often Miss is the more useful starting point than random message-board certainty. Symptoms and labs belong together. One without the other tends to create expensive confusion.

Why Formulation and Route Matter for Lipid Effects

This is where a lot of contradictory anecdotes come from. Different testosterone formulations don’t behave the same way on lipid markers.

According to AACE guidance, oral testosterone formulations that aren’t aromatized can have worse lipid effects, including higher triglycerides and LDL and lower HDL. Injectable and transdermal routes tend to look more neutral or more favorable. AACE also notes that aromatization to estradiol in most non-oral formulations helps maintain a more stable HDL-to-total-cholesterol ratio.

That helps explain why the Asan study, which used injectable testosterone undecanoate, showed favorable lipid effects overall. It isn’t just that “testosterone worked.” The route mattered.

This is also why men shopping clinics should pay attention to how the clinic thinks, not just what it charges. If a provider can’t explain why route, dose, and monitoring matter for lipids, hematocrit, blood pressure, and symptom response, that isn’t a minor omission. That’s the whole job.

For readers comparing providers, Best Online TRT Clinics in 2026 is relevant here because clinic quality variance is real. Some telehealth operators treat testosterone like a subscription box with syringes. Others actually monitor the patient in front of them. Those are different businesses, even if both use the same acronym.

What Monitoring Looks Like: Lipid Panels Before and During TRT

Responsible TRT starts with baseline labs and continues with follow-up labs. This isn’t overkill. It’s what separates treatment from guesswork.

AACE recommends a baseline lipid profile before starting TRT, with a follow-up panel at six to 12 months. The American Urological Association’s testosterone deficiency guideline also emphasizes assessing ASCVD risk factors before therapy begins. That matters for men over 50 because many aren’t walking into treatment with a blank slate. They already have family history, blood pressure issues, elevated ApoB, insulin resistance, or all of the above.

The FDA’s 2025 labeling change is also worth keeping in mind. While the boxed cardiovascular warning was removed, blood pressure monitoring requirements were added. So a competent protocol isn’t just “check testosterone again later.” It’s a full before-and-after comparison: symptoms, total and free testosterone as appropriate, hematocrit, blood pressure, and a lipid panel that shows whether your numbers are improving, stalling, or heading somewhere unhelpful.

This is also where the voice of reason belongs: consult your provider, and make sure the provider is actually monitoring these markers. “How are you feeling?” isn’t a substitute for data. Neither is a clinic dashboard designed to keep the monthly billing cycle emotionally supported.

The Bottom Line for Men Over 50 Considering TRT

For men with confirmed hypogonadism, the data on TRT and lipids is mostly better than the popular narrative suggests.

Across the studies cited here, total cholesterol and LDL usually decrease. Triglycerides often improve. HDL is more variable, but the better studies don’t show the kind of dramatic collapse that online fear-posting implies, especially when therapy stays within physiologic dosing and uses non-oral formulations. The larger safety frame also looks more reassuring after TRAVERSE and the FDA’s 2025 label update.

That doesn’t mean every man should start TRT, and it definitely doesn’t mean every clinic deserves trust. It means the sensible way to evaluate TRT is with diagnosis first, route and dose chosen carefully, and repeat labs that tell you what your body is actually doing rather than what somebody on the internet swears always happens.

Frequently Asked Questions

Does TRT cause high cholesterol or make it worse?

Usually not in men with confirmed low testosterone. The studies cited here generally show total cholesterol and LDL improving, not worsening, after TRT starts. Individual responses vary, which is why baseline and follow-up labs matter.

Can TRT lower my HDL too much?

At physiologic doses, the better evidence suggests HDL is often unchanged or only modestly affected. More pronounced HDL suppression is more commonly linked to supraphysiologic dosing or oral formulations.

How long after starting TRT should I get my lipids checked?

AACE recommends a baseline lipid panel before treatment and a follow-up at roughly six to 12 months. A provider may check sooner or more often if you already have elevated cardiovascular risk or if other markers are moving.

Is the FDA warning about TRT and heart attacks still in effect?

The FDA removed the boxed warning about increased cardiovascular risk from testosterone product labels in February 2025 after the TRAVERSE trial results. The agency added blood pressure monitoring language, so the monitoring burden did not disappear.

Do injections, gels, and other testosterone formulations affect cholesterol differently?

Yes. Route matters. Oral formulations can have less favorable lipid effects, while injectable and transdermal formulations tend to have more neutral or beneficial profiles in the evidence summarized here.

For men over 50 with real testosterone deficiency, TRT’s effect on cholesterol is usually more reassuring than alarming. The smart move isn’t blind optimism or reflex fear. It’s careful diagnosis, a provider who monitors the full picture, and repeat labs that let the evidence beat the folklore.

This article is for informational purposes only and is not financial advice. Consult a qualified professional for personalized guidance.